Efficacy and safety of rivaroxaban in cancer patients with venous thromboembolism: a J'xactly study subanalysis
A subanalysis of the J'xactly study found that the incidence of recurrent/worsening symptomatic VTE and severe bleeding in cancer patients with acute venous thromboembolism (VTE) was not different after treatment with rivaroxaban compared with patients without VTE, according to a report by Dr. Shinji Hisatake and colleagues of the Toho University Graduate School of Medicine in the March issue of the Journal of Cardiology.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
